跳至主要内容
临床试验/JPRN-UMIN000010212
JPRN-UMIN000010212已完成1 期

Evaluation of the safety of transgenic rice containing peptides from Japanese cedar pollen allergens - Evaluation of the safety of transgenic rice containing peptides from Japanese cedar pollen allergens

Department of Molecular Immunology, Institute of DNA Medicine, The Jikei University, School of Medicine.0 个研究点目标入组 18 人开始时间: 2013年3月12日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) A person with a BMI values under 17, or over 28. 2) A person who has hay fever and/or medical history of other allergic disorder. 3) Preliminarily examined positive at more than one of followings; Rhinoscopic examination, Nasal mucosa test, Nasal discharged eosinophil, Intradermal reaction and cedar-pollen specific IgE antibody. 4) A person with a medical history of rice allergy. 5) A person who has a disease which is undergoing treatment 6) A person with serious conditions such as diabetes, hepatic disease, and cardiac disease. 7) A person preliminarily ruled unfit to become a clinical study patient. 8) A person already in another clinical test when this clinical test begins. 9) A person who's presently breastfeeding, in pregnancy, or planning/wishing to be a pregnant during a period of clinical test. 10) A person whom trial investigator has assessed as mismatched participant.

研究者

发起方
Department of Molecular Immunology, Institute of DNA Medicine, The Jikei University, School of Medicine.

相似试验